Nora Doherty – Startup Investor Profile

Nora Doherty, the Vice President of Finance and Managing Director at BioCrossroads, is an investor with a focus on strategic and impactful investments in the life sciences industry. Her investment range typically spans from $100,000 to $5 million, with a sweet spot around $1.5 million. Nora has a track record of investing in companies like Seed BioTech and SonarMed, the latter being in Series C financing in October 2017. She operates from Indianapolis, Indiana, and has a professional career that includes managing key collaborations such as INCAPS and FIHC. Nora’s partnership and collaboration styles are valued in the industry, attracting founders and investors alike, such as Evan MacQueen, Patricia Martin, Anders Richardson, and Alexandre Glaser. Previous Investments: – Seed BioTech – SonarMed Investment Check Size: – Range: $100,000 – $5,000,000 – Sweet Spot: $1.5 million Geographical Preference: – Location: Indianapolis, Indiana

Location: Indianapolis, Indiana

Country: New Zealand

Investment Regions:

Investment Stages: pre-seed, seed

Website: https://www.biocrossroads.com/about-us/our-team/nora-doherty/

AI Reasoning: Searches found only past investments, notably SonarMed (Series C in October 2017). No evidence of investments after 2017 was found on BioCrossroads page or news sources. From October 2017 to the reference date is well over 12 months, so classify as low-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.